Exforge and Breast cancer - a phase IV clinical study of FDA data

Summary:

Breast cancer is reported as a side effect among people who take Exforge (amlodipine besylate; valsartan), especially for people who are female, 60+ old, also take Aspirin, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Breast cancer when taking Exforge. It is created by eHealthMe based on reports of 12,942 people who have side effects when taking Exforge from the FDA, and is updated regularly.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.

What is Breast cancer?

Breast cancer is found to be associated with 1,295 drugs and 1,665 conditions by eHealthMe. Check the latest studies of Breast cancer.

On Jul, 21, 2026

12,942 people reported to have side effects when taking Exforge.
Among them, 50 people (0.39%) have Breast cancer.

Among these 50 people:

What is the gender of people who have Breast cancer when taking Exforge? *

female: 96 %
male: 4 %

What is the age of people who have Breast cancer when taking Exforge? *

What are other drugs people take besides Exforge? *

What are other side effects people have besides Breast cancer? *

Hypotension (abnormally low blood pressure): 6 people, 12.00%
Pneumonia: 5 people, 10.00%
Breast Lump (localized swelling that feels different from the surrounding breast tissue): 4 people, 8.00%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 8.00%
Oedema Peripheral (superficial swelling): 3 people, 6.00%
Fall: 3 people, 6.00%
Memory Loss: 2 people, 4.00%
Metastases To Liver (cancer spreads to liver): 2 people, 4.00%
Joint Pain: 2 people, 4.00%
Nausea (feeling of having an urge to vomit): 2 people, 4.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 8.00%
Type 2 Diabetes: 3 people, 6.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 4.00%
Pain: 2 people, 4.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 4.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 4.00%
Hormone Level Abnormal: 2 people, 4.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 4.00%
Chest Pain: 1 person, 2.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 2.00%

* Approximation only. Some reports may have incomplete information.

Do you take Exforge and have Breast cancer?

- Check whether Breast cancer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exforge:

Exforge (13,350 reports)

Breast cancer treatments and more:

Breast cancer (266,434 reports)

How severe was Breast cancer and when was it recovered:

Breast cancer in Exforge

Expand to all the drugs that have ingredients of amlodipine besylate; valsartan:

Breast cancer and drugs with ingredients of amlodipine besylate; valsartan (55 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Breast cancer:

Breast cancer (1,295 drugs)

Browse all the conditions that are associated with Breast cancer:

Breast cancer (1,665 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; valsartan (the active ingredients of Exforge) and Exforge (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.